Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
August 8, 2016	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001564590-16-023285.pdf 0001564590-16-023285.rtf 0001564590-16-023285.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
August 2, 2016	8-K	Report of unscheduled material events or corporate event	0001193125-16-668500.pdf 0001193125-16-668500.rtf 0001193125-16-668500.xls View HTML
August 2, 2016	4	Statement of changes in beneficial ownership of securities	0001562180-16-002883.pdf 0001562180-16-002883.rtf 0001562180-16-002883.xls View HTML
August 2, 2016	3	Initial filing by director officer or owner of more than ten percent.	0001562180-16-002884.pdf 0001562180-16-002884.rtf 0001562180-16-002884.xls View HTML
July 28, 2016	8-K	Report of unscheduled material events or corporate event	0001193125-16-662191.pdf 0001193125-16-662191.rtf 0001193125-16-662191.xls View HTML
July 7, 2016	4	Statement of changes in beneficial ownership of securities	0001562180-16-002781.pdf 0001562180-16-002781.rtf 0001562180-16-002781.xls View HTML
July 6, 2016	4	Statement of changes in beneficial ownership of securities	0001562180-16-002778.pdf 0001562180-16-002778.rtf 0001562180-16-002778.xls View HTML
July 6, 2016	4	Statement of changes in beneficial ownership of securities	0001562180-16-002777.pdf 0001562180-16-002777.rtf 0001562180-16-002777.xls View HTML
June 21, 2016	8-K	Report of unscheduled material events or corporate event	0001193125-16-627802.pdf 0001193125-16-627802.rtf 0001193125-16-627802.xls View HTML
June 20, 2016	4	Statement of changes in beneficial ownership of securities	0001562180-16-002660.pdf 0001562180-16-002660.rtf 0001562180-16-002660.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax